Activation of an iron uptake mechanism from transferrin in hepatocytes by small-molecular-weight iron complexes: Implications for the pathogenesis of iron-overload disease

Journal of Laboratory and Clinical Medicine

Volumn 133, Issue 2, 1999, Pages 144-151

  Richardson, D R ^a,b   Chua, A C G ^a,b   Baker, E ^a,b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033083678     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90007-0     Document Type: Article

References (47)

1. 1. Young SP, Aisen P. The interaction of transferrin with isolated hepatocytes. Biochim Biophys Acta 1980;633:145-53.
2. 2. Cole ES, Glass J. Transferrin binding and iron uptake in mouse hepatocytes. Biochim Biophys Acta 1983;762:102-10.
3. 3. Page M, Baker E, Morgan EH. Transferrin and iron uptake by rat hepatocytes in culture. Am J Physiol 1984;246:G26-33.
4. 4. Trinder D, Morgan EH, Baker E. The mechanisms of iron uptake by fetal rat hepatocytes in culture. Hepatology 1986;6:852-8.
5. 5. Trinder D, Batey RG, Morgan EH, Baker E. Effect of cellular iron concentration on iron uptake by hepatocytes. Am J Physiol 1990;259:G611-7.
6. 6. Thorstensen K, Trinder D, Zak O, Aisen P. Uptake of iron from N-terminal half transferrin by isolated rat hepatocytes. Evidence of transferrin-receptor-independent iron uptake. Eur J Biochem 1995;232:129-33.
7. 7. Trinder D, Zak O, Aisen P. Transferrin receptor-independent uptake of differic transferrin by human hepatoma cells with antisense inhibition of receptor expression. Hepatology 1996;23:1512-20.
8. 8. Richardson DR, Baker E. The uptake of iron and transferrin by the human melanoma cell. Biochim Biophys Acta 1990;1053:1-12.
9. 9. Richardson DR, Baker E. Two saturable mechanisms of iron uptake from transferrin in human melanoma cells: the effect of transferrin concentration, chelators, and metabolic probes on transferrin and iron uptake. J Cell Physiol 1994;161:160-8.
10. 10. Anderson GJ, Halliday JW, Powell LW. Transferrin receptors in hemochromatosis. Hepatology 1987;7:967-9.
11. 11. Sciot R, Paterson AC, Van Den Oord JJ, Desmert VJ. Lack of hepatic transferrin receptor expression in hemochromatosis. Hepatology 1987;7:831-7.
12. 12. Brissot P, Wright TL, Ma WL, Weisiger RA. Efficient clearance of non-transferrin-bound iron by rat liver. J Clin Invest 1985;76:1463-70.
13. 13. Wright TL, Brissot P, Ma W-L, Weisiger RA. Characterization of non-transferrin-bound iron clearance by rat liver. J Biol Chem 1986;261:10909-14.
14. 14. Baker E, Baker SM, Morgan EH. Characterisation of non-transferrin-bound iron (ferric citrate) uptake by rat hepatocytes in culture. Biochim Biophys Acta 1998;1380:21-30.
15. 15. Graham RM, Morgan EH, Baker E. Ferric citrate uptake by cultured rat hepatocytes is inhibited in the presence of transferrin. Eur J Biochem 1998;253:139-45.
16. 16. Hershko C, Graham G, Bates GW, Rachmilewitz EA. Nonspecific serum iron in thalassemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol 1978;40:255-63.
17. 17. Hershko C, Peto TEA. Non-transferrin plasma iron. Br J Haematol 1987;66:149-51.
18. 18. Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A, Sadler PJ. Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J Biol Chem 1989;264:4417-22.
19. 19. Batey RG, Chung Fung PL, Shamir S, Sherlock S. A non-transferrin-bound serum iron in idiopathic hemochromatosis. Dig Dis Sci 1980;25:340-6.
20. 20. Gutteridge JMC, Rowley DA, Griffiths E, Halliwell B. Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin Sci 1985;68:463-7.
21. 21. Hanks JH, Wallace RE. Relation of oxygen and temperature in preservation of tissues by refrigeration. Proc Soc Exp Biol Med 1949;71:196-200.
22. 22. Richardson DR, Baker E. The effect of desferrioxamine and ferric ammonium citrate on the uptake of iron by the membrane iron-binding component of human melanoma cells. Biochim Biophys Acta 1992;1103:275-80.
23. 23. Richardson DR, Baker E. Two mechanisms of iron uptake from transferrin by melanoma cells. The effect of desferrioxamine and ferric ammonium citrate. J Biol Chem 1992;267:13972-9.
24. 24. Goto Y, Paterson M, Listowsky I. Iron uptake and regulation of ferritin synthesis by hepatoma cells in hormone-supplemented serum-free medium. J Biol Chem 1983;258:5248-55.
25. 25. Richardson D, Baker E. The uptake of inorganic iron complexes by human melanoma cells. Biochim Biophys Acta 1991;1093:20-8.
26. 26. Hinegardner RT. An improved fluorometric assay for DNA. Biochemistry 1971;39:197-201.
27. 27. Richardson DR, Ponka P. Identification of a mechanism of iron uptake by cells that is stimulated by hydroxyl radicals generated via the iron-catalysed Haber-Weiss reaction. Biochim Biophys Acta 1995;1269:105-14.
28. 28. Randell EW, Parkes JG, Olivieri NF, Templeton DM. Uptake of non-transferrin-bound iron by both reductive and non-reductive processes is modulated by intracellular iron. J Biol Chem 1994;269:16046-53.
29. 29. Parkes JG, Randell EW, Olivieri NF, Templeton DM. Modulation by iron loading and chelation of the uptake of non-transferrin-bound iron by human liver cells. Biochim Biophys Acta 1995;1243:373-80.
30. 30. Hentze MW, Kühn LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA 1996;93:8175-82.
31. 31. Richardson DR, Ponka P. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim Biophys Acta 1997;1331:1-40.
32. 32. Kaplan J, Jordan I, Sturrock A. Regulation of the transferrin-independent iron transport system in cultured cells. J Biol Chem 1991;266:2997-3004.
33. 33. Parkes JG, Hussain RA, Olivieri NF, Templeton DM. Effects of iron loading on uptake, speciation, and chelation of iron in cultured myocardial cells. J Lab Clin Med 1993;122:36-47.
34. 34. Engle M, Erlandson M, Smith C. Late cardiac complications of chronic, severe refractory anaemia with hemochromatosis. Circulation 1964;30:698-705.
35. 35. Modell B, Berdoukas V. The clinical approach to thalassemia. New York: Grune and Stratton; 1984.
36. 36. Richardson DR, Ponka P. Pyridoxal isonicotinoyl hydrazone and its analogs: potential orally effective iron chelating agents for the treatment of iron overload disease. J Lab Clin Med 1998;131:306-14.
37. 37. Petris MJ, Mercer JFB, Culvenor G, Lockhart P, Gleeson PA, Camakaris J. Ligand-regulated transport of the Menkes copper P-type ATPase efflux pump from the Golgi apparatus to the plasma membrane: a novel mechanism of regulated trafficking. EMBO J 1996;15:6084-95.
38. 38. Morgan EH. Membrane transport of non-transferrin-bound iron by reticulocytes. Biochim Biophys Acta 1988;943:428-39.
39. 39. Jordan I, Kaplan J. The mammalian transferrin-independent iron transport system may involve a surface ferrireductase activity. Biochem J 1994;302:875-9.
40. 40. Inman RS, Coughlan MM, Wessling-Resnick M. Extracellular ferrireductase activity of K562 cells in coupled to transferrin-independent iron transport. Biochemistry 1994;33:11850-7.
41. 41. Crane FL, Sun IL, Clarke MG, Grebing C, Low H. Transplasma-membrane redox systems in growth and development. Biochim Biophys Acta 1985;811:233-64.
42. 42. Sun IL, Navas P, Crane FL, Morre DJ, Low H. NADH diferric transferrin reductase in liver plasma membrane. J Biol Chem 1987;262:15915-21.
43. 43. Thorstensen K, Aisen P. Release of iron from diferric transferrin in the presence of rat liver membranes: no evidence of a diferric transferrin reductase. Biochim Biophys Acta 1990;1052:29-35.
44. 44. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, et al. Cloning and characterization of a mammalian proton-coupled metal ion transporter. Nature 1997;388:482-8.
45. 45. Fleming MD, Trenor CCI, Su MA, Foernzler D, Beier DR, Dietrich WF, et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 1997;16:383-6.
46. 46. Fleming MD, Romano MA, Su MA, Garrick LM, Garrick MD, Andrews NC. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci USA 1998;95:1148-53.
47. 47. Gutierrez JA, Yu J, Rivera S, Wessling-Resnick M. Functional expression cloning and characterization of SFT, a stimulator of Fe transport. J Cell Biol 1997;139:895-905.